We embody medical progress

Complex Pharmaceuticals was founded in 2024 by industry-leading experts with decades of experience in the pharmaceutical industry.

Our goal: To set new benchmarks in pharmaceutical product development through innovation

Complex Pharmaceuticals combines professional expertise with state-of-the-art technology. Based in Vienna, we provide innovative solutions in the manufacturing, packaging, and wholesale of pharmaceutical products. Through agile processes and high-quality standards, we support the secondary packaging of micro and small batches and help shape the pharmaceutical value chain for the future.

Our expertise as a pharmaceutical manufacturer and specialist in secondary packaging enables not only the market launch of approved pharmaceutical products but also supports clinical trials with tailor-made packaging concepts that meet the highest regulatory standards.

With a clear focus on quality, efficiency, and precision, we drive the development of pharmaceutical products and strengthen our position as a reliable partner for the pharmaceutical industry.

How we work

Teamwork

Successful innovations arise from collaboration on equal terms. At Complex Pharmaceuticals we encourage the open exchange of knowledge and interdisciplinary cooperation for optimal solutions in the pharmaceutical industry.

Agile and flexible

Thanks to our in-house packaging production and lean structures, we can respond flexibly to our clients’ requirements – whether they involve small batches, clinical trials or large-scale market launches.

Passion for R&D

Progress is only possible through continuous development. Driven by enthusiasm for new technologies and scientific insights, we advance the optimisation of therapies and the development of new solutions.

Expertise: Rare diseases – Orphan diseases

Rare diseases, also known as “orphan diseases,” are defined according to their frequency – although this varies around the world. In Europe, a disease is considered rare if it affects fewer than 5 in 10,000 people. Around 30 million people in Europe and around 400,000 in Austria suffer from one of the 6,000 known rare diseases. Of these, 80% are genetic in origin, while the remaining 20% result from infections, allergies, or environmental factors.

Orpha Trade – Pharmaceutical product development and license management

Complex Pharmaceuticals is a subsidiary of Orpha Trade GmbH, a renowned company based in Vienna that specialises in the granting, management, and strategic development of pharmaceutical product licenses.